Brugada Syndrome (BrS): Clinical Trials

1 trial for Brugada Syndrome (BrS), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Not yet recruiting 1

Follow Brugada Syndrome (BrS): new trials by email Literature Review of Brugada Syndrome (BrS) trials Research Report on Brugada Syndrome (BrS)

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Empagliflozin as a Potential Therapeutic Solution for Patients With Brugada Syndrome
Empagliflozin (EMPA) - Brugada Syndrome (BrS)
Phase 2Not yet recruitingNational Taiwan University Hospital102025-09-152025-09-12

Narrower conditions

Brugada Syndrome (1)

Broader conditions

Arrhythmias, Cardiac (1)  ·  Cardiac Conduction System Disease (1)  ·  Cardiovascular Diseases (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, Inborn (1)  ·  Heart Diseases (1)

Interventions

empagliflozin (1)

Sponsors

National Taiwan University Hospital (1)

Countries

Taiwan (1)

Top investigators

Joseph Wu, MD, Phd (1)